[go: up one dir, main page]

NO20020665D0 - Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner - Google Patents

Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner

Info

Publication number
NO20020665D0
NO20020665D0 NO20020665A NO20020665A NO20020665D0 NO 20020665 D0 NO20020665 D0 NO 20020665D0 NO 20020665 A NO20020665 A NO 20020665A NO 20020665 A NO20020665 A NO 20020665A NO 20020665 D0 NO20020665 D0 NO 20020665D0
Authority
NO
Norway
Prior art keywords
avermectins
determines
ratio
streptomyces avermitilis
avermitilis gene
Prior art date
Application number
NO20020665A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020665L (no
Inventor
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20020665L publication Critical patent/NO20020665L/no
Publication of NO20020665D0 publication Critical patent/NO20020665D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020665A 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner NO20020665D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
PCT/IB2000/000996 WO2001012822A1 (en) 1999-08-12 2000-07-19 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (2)

Publication Number Publication Date
NO20020665L NO20020665L (no) 2002-02-11
NO20020665D0 true NO20020665D0 (no) 2002-02-11

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020665A NO20020665D0 (no) 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner

Country Status (37)

Country Link
US (8) US6248579B1 (es)
EP (1) EP1200605B1 (es)
JP (2) JP3688640B2 (es)
KR (1) KR100486006B1 (es)
CN (1) CN1186447C (es)
AP (2) AP2002002419A0 (es)
AR (1) AR021450A1 (es)
AT (1) ATE283363T1 (es)
AU (1) AU779756B2 (es)
BG (1) BG106478A (es)
BR (1) BR0013093A (es)
CA (1) CA2381427A1 (es)
CO (1) CO5290296A1 (es)
CZ (1) CZ2002297A3 (es)
DE (1) DE60016231T2 (es)
EA (1) EA004569B1 (es)
ES (1) ES2231214T3 (es)
GT (2) GT200000138A (es)
HK (1) HK1046536B (es)
HR (1) HRP20020131A2 (es)
HU (1) HUP0202517A2 (es)
IL (1) IL147562A0 (es)
IS (1) IS6249A (es)
MA (1) MA26811A1 (es)
MX (1) MXPA02001514A (es)
NO (1) NO20020665D0 (es)
OA (1) OA11997A (es)
PA (1) PA8499201A1 (es)
PE (1) PE20010697A1 (es)
PL (1) PL353770A1 (es)
PT (1) PT1200605E (es)
SK (1) SK1382002A3 (es)
TN (1) TNSN00170A1 (es)
UY (1) UY26287A1 (es)
WO (1) WO2001012822A1 (es)
YU (1) YU8402A (es)
ZA (1) ZA200201071B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230600B1 (hu) * 1999-08-12 2017-02-28 Zoetis Services Llc Az avermektinek B2:B1 arányát befolyásoló Streptomyces avermitilis gén
AU2003210850A1 (en) 2002-02-05 2003-09-02 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
DE60326824D1 (de) * 2002-02-12 2009-05-07 Pfizer Prod Inc Streptomyces avermitilis gen zur regulierung des verhältnisses der b2:b1 avermectine
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
EP1597271B1 (de) * 2003-01-31 2013-03-06 Max-Delbrück-Centrum Für Molekulare Medizin Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
ES2054822T3 (es) 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
DK0711349T3 (da) 1993-07-30 2003-11-24 Pfizer Gener, der koder for forgrenet alfaketosyredehydrogenasekompleks fra Streptomyces avermitilis
DK0722453T3 (da) * 1993-10-05 1999-12-27 Pfizer Fremgangsmåde og antiparasitiske mellemprodukter til doramectin
FI942725A7 (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
HRP20000539A2 (en) * 1998-02-13 2001-04-30 Pfizer Prod Inc Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Also Published As

Publication number Publication date
IL147562A0 (en) 2002-08-14
AP2002002419A0 (en) 2002-03-31
US20030129636A1 (en) 2003-07-10
OA11997A (en) 2006-04-18
PT1200605E (pt) 2005-04-29
NO20020665L (no) 2002-02-11
AU5702100A (en) 2001-03-13
IS6249A (is) 2002-01-25
ZA200201071B (en) 2003-06-25
CO5290296A1 (es) 2003-06-27
ATE283363T1 (de) 2004-12-15
GT200000138CA (es) 2002-02-02
US20030134313A1 (en) 2003-07-17
HRP20020131A2 (en) 2003-12-31
HK1046536B (zh) 2005-05-13
CA2381427A1 (en) 2001-02-22
CZ2002297A3 (cs) 2002-08-14
TNSN00170A1 (fr) 2005-11-10
PA8499201A1 (es) 2001-12-14
US20010016350A1 (en) 2001-08-23
PE20010697A1 (es) 2001-07-05
US7029887B2 (en) 2006-04-18
DE60016231D1 (de) 2004-12-30
US6511841B2 (en) 2003-01-28
CN1370239A (zh) 2002-09-18
EP1200605A1 (en) 2002-05-02
GT200000138A (es) 2002-02-02
MXPA02001514A (es) 2002-07-02
AU779756B2 (en) 2005-02-10
SK1382002A3 (en) 2002-11-06
PL353770A1 (en) 2003-12-01
US6833263B2 (en) 2004-12-21
JP2003507018A (ja) 2003-02-25
YU8402A (sh) 2006-03-03
ES2231214T3 (es) 2005-05-16
EA004569B1 (ru) 2004-06-24
US20050196777A1 (en) 2005-09-08
JP3688640B2 (ja) 2005-08-31
EA200200057A1 (ru) 2002-06-27
US20030124607A1 (en) 2003-07-03
WO2001012822A1 (en) 2001-02-22
JP2005198658A (ja) 2005-07-28
BG106478A (bg) 2004-02-27
AR021450A1 (es) 2002-07-17
KR100486006B1 (ko) 2005-05-03
HK1046536A1 (en) 2003-01-17
HUP0202517A2 (hu) 2002-11-28
US7259241B2 (en) 2007-08-21
EP1200605B1 (en) 2004-11-24
US6248579B1 (en) 2001-06-19
US6509159B2 (en) 2003-01-21
US20030129635A1 (en) 2003-07-10
DE60016231T2 (de) 2005-12-08
MA26811A1 (fr) 2004-12-20
AP2002002417A0 (en) 2002-03-31
US20010024818A1 (en) 2001-09-27
UY26287A1 (es) 2001-03-16
KR20020022809A (ko) 2002-03-27
CN1186447C (zh) 2005-01-26
BR0013093A (pt) 2002-08-13

Similar Documents

Publication Publication Date Title
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
AU2002363246A1 (en) Game with multiple chambers
AU2001282522A1 (en) Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
NO20042112L (no) Anvendelse av glycosider av mono- og diacylglycerol som anti-inflammatoriske midler.
DK1131331T3 (da) 13-leddede azalider og deres anvendelse som antibiotiske midler
NO20020665D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner
AU2002330717A1 (en) Monosaccharide derivatives
NO20004044D0 (no) Streptomyces Avertimilis gen som styrer forholdet av B2:B1 avermectiner
NO20020664L (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner
ZA200405345B (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AU2930601A (en) Methods of increasing the glucose responsiveness of pancreatic beta-cells
AU2002317415A1 (en) Azalide antibiotic compositions
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2003285599A1 (en) Novel semisynthetic macrolide antibiotics of the azalide series
AU2690500A (en) Avermectin aglycon synthase genes
AU2003243789A1 (en) 11-c-substituted ketolides
AUPR282501A0 (en) Expression facilitating nucleotides
AU2002337486A1 (en) War game
AU2002230657A1 (en) Haplotypes of the sah gene
AU2002258684A1 (en) Assay methods for o-g1cnac transferase activity
AU2002359534A1 (en) Nucleoside analog libraries
AU2001268231A1 (en) Haplotypes of the pfkfb2 gene
HK1071531A (en) Game with multiple chambers
AU2002226394A1 (en) Nucleoside diphosphate hydrolase
AU2002317711A1 (en) Nucleoside derivatives for library preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application